ABIOMED, INC.

ABMDUnited States

30 filed reports · 391 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$1.03B

FY2022 · to Mar 31, 2022

up +21.7% vs $848M

10-K

Net income

$137M

FY2022 · to Mar 31, 2022

down −39.5% vs $226M

10-K

Operating income

$141M

FY2022 · to Mar 31, 2022

down −38.7% vs $230M

10-K

Latest quarter

Revenue

$266M

Q2 FY2023 · to Sep 30, 2022

up +7.2% vs $248M

10-Q

Net income

$106M

Q2 FY2023 · to Sep 30, 2022

up +86.4% vs $57M

10-Q

Operating income

$58M

Q2 FY2023 · to Sep 30, 2022

down −4.0% vs $60.4M

10-Q

Filed reports

30 reports · Jun 2015 to Sep 2022

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR233,971Jun 2015 to Sep 2022
Annual · 10-KSEC EDGAR73,198Mar 2016 to Mar 2022

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q210-Q2022-09-302022-11-03408Open
FY2023 Q110-Q2022-06-302022-08-04230Open
FY202210-K2022-03-312022-05-20778Open
FY2022 Q310-Q2021-12-312022-02-03274Open
FY2022 Q210-Q2021-09-302021-10-28195Open
FY2022 Q110-Q2021-06-302021-08-05175Open
FY202110-K2021-03-312021-05-21460Open
FY2021 Q310-Q2020-12-312021-02-04202Open
FY2021 Q210-Q2020-09-302020-11-06170Open
FY2021 Q110-Q2020-06-302020-08-06167Open
FY202010-K2020-03-312020-05-21430Open
FY2020 Q310-Q2019-12-312020-02-06278Open

Financial data

391 concepts · 7,169 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial388 concepts · 6,999 facts · Mar 2014 to Sep 2022

  • Cash and cash equivalents at carrying value45 · Mar 2014 to Sep 2022
  • Income loss from continuing operations before income taxes extraordinary items noncontrolling interest44 · Mar 2014 to Sep 2022
  • Capital expenditures incurred but not yet paid43 · Mar 2014 to Sep 2022
  • Comprehensive income net of tax43 · Mar 2014 to Sep 2022
  • Costs and expenses43 · Mar 2014 to Sep 2022
  • Deferred income tax expense benefit43 · Mar 2014 to Sep 2022
  • Income taxes paid43 · Mar 2014 to Sep 2022
  • Income tax expense benefit43 · Mar 2014 to Sep 2022
  • Increase decrease in accounts payable43 · Mar 2014 to Sep 2022
  • Increase decrease in accounts receivable43 · Mar 2014 to Sep 2022
  • Increase decrease in accrued liabilities and other operating liabilities43 · Mar 2014 to Sep 2022
  • Increase decrease in inventories43 · Mar 2014 to Sep 2022
  • Increase decrease in prepaid deferred expense and other assets43 · Mar 2014 to Sep 2022
  • Inventory write down43 · Mar 2014 to Sep 2022
  • Net income loss43 · Mar 2014 to Sep 2022
  • Operating income loss43 · Mar 2014 to Sep 2022
  • Other comprehensive income loss available for sale securities adjustment net of tax43 · Mar 2014 to Sep 2022
  • Other comprehensive income loss foreign currency transaction and translation adjustment net of tax43 · Mar 2014 to Sep 2022
  • Other comprehensive income loss net of tax43 · Mar 2014 to Sep 2022
  • Payments related to tax withholding for share based compensation43 · Mar 2014 to Sep 2022
  • Payments to acquire marketable securities43 · Mar 2014 to Sep 2022
  • Payments to acquire property plant and equipment43 · Mar 2014 to Sep 2022
  • Proceeds from stock options exercised43 · Mar 2014 to Sep 2022
  • Research and development expense43 · Mar 2014 to Sep 2022

Geography2 concepts · 108 facts · Mar 2014 to Sep 2022

  • Revenue94 · Mar 2017 to Sep 2022
  • Percentage Of Revenues By Geographic Regions14 · Mar 2014 to Jun 2017

Product1 concept · 62 facts · Mar 2017 to Sep 2022

  • Revenue62 · Mar 2017 to Sep 2022

Segments

170 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement geographicalsrt:StatementGeographicalAxis6 members · 94 facts

  • United States28 · Mar 2017 to Sep 2022
  • International24 · Mar 2017 to Dec 2021
  • Europe [Member]14 · Mar 2019 to Sep 2022
  • Japan14 · Mar 2019 to Sep 2022
  • Outside the U.S. [Member]7 · Mar 2020 to Sep 2022
  • Rest of world [Member]7 · Mar 2020 to Sep 2022

Product or service3 members · 62 facts

  • Service and Other28 · Mar 2017 to Sep 2022
  • Impella Product19 · Mar 2017 to Mar 2021
  • Product15 · Dec 2019 to Sep 2022

Statement geographicalus-gaap:StatementGeographicalAxis1 member · 14 facts

  • International14 · Mar 2014 to Jun 2017

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of ABIOMED, INC. (ABMD) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 20, 2026) and refreshed every few hours.

ABIOMED, INC. (ABMD): FY2022 revenue $1.03B · FactIQ